Evommune
Financing Round
- Series A
Round Led by Symbiosis
Developer of a tissue-based approach designed to advance insights for inflammatory diseases. Evommune develops transformative medicines to advance insights and accelerate the development of medicines. The company has built a robust pipeline of unique therapies with the potential to help patients with chronic inflammatory diseases.
View Website
Modality
- Small Molecule
Indications
- Dermatology
- Immunology
Development Status
- Phase 1